N-Acetyl Semax Amidate

N-Acetyl Semax Amidate, often referred to as NA-Semax or Semax Amidate, is a synthetic peptide derived from adrenocorticotropic hormone (ACTH). It is a modified form of Semax, which is itself an analog of ACTH(4-10) with an additional Pro-Gly-Pro sequence. The N-acetyl and amidate modifications are introduced to potentially enhance its stability and bioavailability, influencing its interaction with the central nervous system. Semax peptides have been developed and studied in Russia, where Semax is used clinically. N-Acetyl Semax Amidate is not approved for medical use in many other countries, including the United States, and is typically available as a research chemical. Research into this peptide focuses on its potential neuroregulatory properties and its involvement in various brain functions, including those related to cognition and stress response (as noted by research literature in databases like PubChem).